MedPath
HSA Approval

DURO-TUSS CHESTY COUGH LIQUID

SIN10014P

DURO-TUSS CHESTY COUGH LIQUID

DURO-TUSS CHESTY COUGH LIQUID

September 21, 1998

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Licence HolderINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

ORAL

Medical Information

R05CB02

bromhexine

Manufacturer Information

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Ensign Laboratories Pty Ltd

Active Ingredients

BROMHEXINE HCl

12 mg/15 ml

Bromhexine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DURO-TUSS CHESTY COUGH LIQUID - HSA Approval | MedPath